​

Merrimack Pharmaceuticals Stock (NASDAQ:MACK)

Chart

Previous Close

$15.13

52W Range

$11.53 - $15.89

50D Avg

$14.80

200D Avg

$13.36

Market Cap

$223.97M

Avg Vol (3M)

$182.63K

Beta

1.42

Div Yield

$15.10

MACK Company Profile

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Mar 29, 2012

Website

MACK Performance

Latest Earnings Call Transcripts

Q3 18Nov 07, 18 | 5:00 PM
Q2 18Aug 07, 18 | 5:00 PM
Q1 18May 08, 18 | 5:00 PM

Peer Comparison

TickerCompany
ZVRAZevra Therapeutics, Inc.
CRGXCARGO Therapeutics, Inc. Common Stock
SLRNAcelyrin, Inc.
SPPISpectrum Pharmaceuticals, Inc.
TickerGate Footer Logo

Tickergate is an AI research agent that helps investors analyze companies, filings, and markets faster and smarter.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
PrivacyTerms
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks